Coinciding with World Diabetes Day, the National Health Service (NHS) in England is providing funding for Flash Glucose Monitors (FGM) for Type 1 Diabetic (T1D) patients. The move is set to change the lives of tens of thousands of people in the country.
A slew of measures have been put forward that empower Medicare Part D plans, whether stand-alone or Medicare Advantage. They don’t, however, necessarily empower the Medicare beneficiary.
A startup cofounded by Harvard genomics pioneer George Church and two Forbes 30 Under 30 members is now seeking people who want to have their genome sequenced.
Men with low testosterone often experience depression symptoms, but using testosterone therapy to treat them has been controversial. Now a new analysis suggests why it’s an option worth considering, at least for some.